Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-12-30
1997-03-11
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514529, 514530, 514531, 514532, 514533, 514534, 514535, 514546, 514547, 514548, 514551, 514912, 560 36, 560 39, 560 43, 560115, 560121, 560123, 560124, 560170, A61K 3124, C07C22934
Patent
active
056101880
ABSTRACT:
Compounds of the formula ##STR1## wherein the variables are defined in the specification. The compounds and their salts are soft anticholinergic/antisecretory agents especially useful as mydriatics and as antiperspirants.
REFERENCES:
patent: 2814623 (1957-11-01), Moffett
patent: 3312709 (1967-04-01), MacMillan
patent: 3557125 (1971-01-01), Zeile et al.
patent: 3649630 (1972-03-01), Meunier et al.
patent: 4160099 (1979-07-01), Bodor
patent: 4479932 (1984-10-01), Bodor
patent: 4771059 (1988-09-01), Bodor
patent: 4916145 (1990-04-01), Tilley et al.
patent: 5208247 (1993-05-01), Trova et al.
patent: 5216170 (1993-06-01), Lindel et al.
patent: 5223528 (1993-06-01), Hammer et al.
patent: 5258388 (1993-11-01), Hammer et al.
patent: 5418244 (1995-05-01), Hammer et al.
CA 63: 13137g, 1965.
CA 63: 13137f, 1965.
CA 62: 2736b, 1965.
CA 62: 469g, 1965.
CA 55: 581g, 1961.
Bodor, in Advances in Drug Research, ed. Bernard Testa, vol. 13, Academic Press, London, 1984, 256-263, 311-312, 322-323.
Notari, in Design of Biopharmaceutical Properties through Prodrugs and Analogs, ed. Edward B. Roche, American Pharmaceutical Association Academy of Pharmaceutical Sciences, Washington, D.C., 1977, 68-69, 78-79.
Bodor, in Design of Prodrugs, ed. H. Bundgaard, Elsevier Science Publishers B.V., Amsterdam, 1985, 333-353.
Bundgaard, in Design of Prodrugs, ed. H. Bundgaard, Elsevier Science Publishers B.V., Amsterdam, 1985, v-vii.
Bundgaard, in Design of Prodrugs ed. H. Bundgaard, Elsevier Science Publishers B.V., Amsterdam, 1985, 1-4.
Hadgraft, in Design of Prodrugs, ed. H. Bundgaard, Elsevier Science Publishers B.V., Amsterdam, 1985, 271-289.
Harper, in Absorption and Distribution of Drugs, ed. T. B. Binns, The Williams and Wilkins Company, Baltimore, MD, 1964, 103-108.
The Pharmacological Basis of Therapeutics, fifth edition, eds. L. S. Goodman and A. Gilman, MacMillan Publishing Co., Inc., New York, 1975, 515-516.
MacMillan et al, J. Investigative Dermatology, 43, 363, 371-377 (1964).
Cutting's Handbook of Pharmacology, Seventh edition, ed. T. Z. Cs aky et al, Appleton-Century-Crofts, Norwalk, Connecticut, 1984, 622-638.
Bodor et al, Journal of Biopharmaceutical Sciences, 1(3), 215-223 (1990).
Hammer et al, Current Eye Research, vol. 10, No. 6, 565-570 (1991).
Hammer et al, Drug Design and Delivery, vol. 2, 207-219 (1988).
Bodor et al, J. Med. Chem., 1980, 23, 474-480.
Bodor, Advances in Drug Research, vol. 13, 255-331 (1984).
Hammer et al, Drug Design and Delivery, 1988, vol. 2, 207-219.
Salmon-Legagneur et al, Bull. Soc. Chim. France 8, 2270-2275 (1965).
Kulp et al, J. Med. Chem. 7(6), 831 (1964).
Diaz Gomez et al, Biochemical Pharmacology, vol. 20, pp. 929-942 (1971).
Chemical Abstracts 57, 8541d-8542b (1962), Buttini et al.
Kaiser et. al., Tje Journal of Org. Chem., vol. 35, No. 2, 410-414 1970.
Makosza et. al., Rocz. Chem., 49, 297-306 1975.
Bodor Nicholas S.
Hammer Richard H.
Kumar Shailendra
University of Florida
LandOfFree
Anticholinergic compounds, compositions and methods of treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticholinergic compounds, compositions and methods of treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticholinergic compounds, compositions and methods of treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-443962